Lifeloc Technologies (LCTC) AI Stock Analysis

• Market Cap: $8.73M
• Dividend Yield: N/A
• Average Volume (3M): 155.00
• Price to Earnings (P/E): ―
• Beta (1Y): <0.01
• Revenue Growth: -9.88%
• EPS Growth: -179.39%
• Country: US
• Employees: 39
• Sector: Technology
• Sector Strength: 81
• Industry: Hardware, Equipment & Parts
• EPS (TTM): -0.14
• Shares Outstanding: 2,752,616
• 10 Day Avg. Volume: 165
• 30 Day Avg. Volume: 155
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.06
• Enterprise Value/Revenue: 1.09
• Enterprise Value/Gross Profit: 2.68
• Enterprise Value/Ebitda: -9.53
• 1Y Price Target: $3.50
• Price Target Upside: 5.74% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 52 Neutral
• Price Target: $3.50 ▲(5.74% Upside)

Lifeloc Technologies' overall stock score is primarily impacted by its financial performance challenges, including declining revenues and negative profitability margins. Technical analysis provides some support with a stable upward trend, but valuation concerns due to a negative P/E ratio and lack of dividend yield weigh heavily on the score. The absence of earnings call insights and corporate events leaves these areas unaddressed.

Lifeloc Technologies Business Overview & Revenue Model

Company Description

Lifeloc Technologies, Inc. (LCTC) is a leading provider of advanced breath alcohol testing solutions, primarily serving law enforcement, workplace safety, and various industrial sectors. The company specializes in the design and manufacturing of portable and stationary breath alcohol testers, as well as software and accessories that enhance the functionality and usability of its products. With a commitment to innovation, Lifeloc Technologies focuses on delivering accurate, reliable, and user-friendly devices that meet the stringent requirements of regulatory agencies and corporate clients alike.

How the Company Makes Money

Lifeloc Technologies generates revenue through the sale of its breath alcohol testing devices, which include both portable and fixed models. Key revenue streams include direct product sales to law enforcement agencies, corporate clients for workplace safety programs, and distribution partnerships with resellers and integrators. In addition to hardware sales, the company earns income from software solutions that complement its testing devices, as well as ongoing maintenance and calibration services. Strategic partnerships with public safety organizations and industry stakeholders further enhance Lifeloc's market presence and revenue potential, as these collaborations often lead to bulk purchases and long-term contracts.

Lifeloc Technologies Financial Statement Overview

Summary

Lifeloc Technologies faces challenges with profitability and cash flow management, despite maintaining a resilient balance sheet. The income statement shows declining revenue and negative margins, while cash flow analysis highlights liquidity challenges. However, the balance sheet is stable with low debt levels.

Income Statement

Lifeloc Technologies shows weak performance in its income statement with a declining revenue trend from 2023 to TTM. The gross profit margin is moderate but overshadowed by negative net and EBIT margins, indicating operational inefficiencies and losses. The company has struggled with consistent negative net income over the periods.

Balance Sheet

The balance sheet remains relatively stable with a high equity ratio and manageable debt levels. Debt-to-equity ratio is low, reflecting conservative leverage strategy. However, the return on equity is negative due to ongoing losses, indicating inefficiencies in generating returns from equity investments.

Cash Flow

Cash flow analysis reveals volatility with a recent positive shift in operating cash flow for TTM, a positive indicator. However, free cash flow remains negative, highlighting potential liquidity challenges. The operating cash flow to net income ratio shows improvement, but overall cash flow management needs enhancement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.49M	8.54M	9.33M	8.48M	7.05M	6.36M
Gross Profit	3.45M	3.45M	4.04M	3.07M	3.06M	2.18M
EBITDA	-969.78K	-1.07M	139.45K	98.46K	-2.02K	-777.96K
Net Income	-1.16M	-1.05M	205.61K	-455.76K	675.97K	-921.93K
Balance Sheet
Total Assets	8.62M	8.72M	8.69M	8.52M	8.95M	8.54M
Cash, Cash Equivalents and Short-Term Investments	995.75K	1.24M	1.77M	2.35M	2.57M	2.20M
Total Debt	1.84M	1.80M	1.22M	1.27M	1.32M	1.79M
Total Liabilities	2.74M	2.50M	2.33M	2.36M	2.36M	2.64M
Stockholders Equity	5.89M	6.23M	6.36M	6.16M	6.59M	5.90M
Cash Flow
Free Cash Flow	-85.48K	-2.02M	-533.96K	-168.25K	-85.53K	-1.41M
Operating Cash Flow	145.35K	-1.33M	-525.74K	54.33K	182.94K	-1.36M
Investing Cash Flow	-418.70K	-689.45K	-8.21K	-222.58K	-268.48K	-46.27K
Financing Cash Flow	1.90M	1.49M	-52.18K	-50.66K	462.13K	419.13K

Lifeloc Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.31
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Positive. The current price of 3.31 is above the 20-day moving average (MA) of 3.22, above the 50-day MA of 3.15, and above the 200-day MA of 3.21, indicating a bullish trend. The MACD of 0.01 indicates Positive momentum. The RSI at 58.65 is Neutral, neither overbought nor oversold. The STOCH value of 53.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LCTC.

Lifeloc Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$35.56B	9.00	-10.49%	1.86%	8.45%	-8.32%
LCTC	52 Neutral	$8.73M	―	-19.84%	―	-9.88%	-179.39%
SLNH	46 Neutral	$14.37M	―	-2533.43%	―	-26.87%	45.53%
WATT	40 Underperform	$9.88M	―	-232.47%	―	433.51%	71.19%
IMTE	―	$3.19M	―	-85.42%	―	―	―
SOBR	―	$4.85M	―	-133.49%	―	―	―
OST	―	$9.96M	―	-163.86%	―	―	―

Lifeloc Technologies Corporate Events

Lifeloc Technologies Amends License Agreement with Sandia

On August 26, 2025, Lifeloc Technologies amended its license agreement with National Technology & Engineering Solutions of Sandia, LLC. The amendment addresses U.S. competitiveness requirements, change of control, assignment, and milestone obligations, potentially impacting the company’s operational strategies and stakeholder interests.